Diamyd Medical: Phase II results will be released June 16, 2003
27. Mai 2003 10:12 ET
|
Diamyd Medical
STOCKHOLM, Sweden, May 27, 2003 (PRIMEZONE) -- Diamyd Medical (O-list) (Stockholm:DIAMb) is planning to present its phase II study with the diabetes vaccine Diamyd in a press release on Monday June...
Diamyd Medical AB Second Quarter Report 02/03
16. April 2003 03:33 ET
|
Diamyd Medical
STOCKHOLM, Sweden, April 16, 2003 (PRIMEZONE) -- Diamyd Medical AB (publ) (SSE:DIAMb):
December 1, 2002 - February 28, 2003
- Sales during the period were SEK 358,000 (393,000).
- Earnings ...
All patients in Diamyd's diabetes study included
10. Januar 2003 10:35 ET
|
Diamyd Medical
STOCKHOLM, Sweden, Jan. 10, 2003 (PRIMEZONE) -- Diamyd Medical (SSE:DIAMb) is developing a GAD vaccine for insulin-dependent diabetes. The company reports that patient recruitment has been concluded,...
Diamyd Medical's Competitor Signs Multimillion Dollar Agreement
07. August 2002 11:26 ET
|
Diamyd Medical
STOCKHOLM, Sweden, Aug. 7, 2002 (PRIMEZONE) -- Aventis has entered into an agreement with Peptor from Israel that involves Aventis investing more than USD 100 million in Peptor's diabetes project....